XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Dec. 31, 2019 29,829,916        
Balance at Dec. 31, 2019 $ 3 $ 31,923 $ (12,730) $ 0 $ 19,196
Common shares issued upon exercise of stock options (in shares) 327,500        
Common shares issued upon exercise of stock options $ 0 566 0 0 566
Common shares issued upon vesting of restricted stock units (in shares) 101,557        
Common shares issued upon vesting of restricted stock units $ 0 0 0 0 0
Share-based compensation expense 0 1,563 0 0 1,563
Net loss for the period $ 0 0 (9,024) 0 (9,024)
Common shares issued upon exercise of warrants at $6.50 per share (in shares) 261,679        
Common shares issued upon exercise of warrants at $6.50 per share $ 0 1,646 0 0 1,646
Common shares issued upon exercise of warrants at $3.00 per share, net of issuance costs (in shares) 253,125        
Common shares issued upon exercise of warrants at $3.00 per share, net of issuance costs $ 0 735 0 0 735
Common shares issued upon exercise of warrants at $5.00 per share, net of issuance costs (in shares) 3,593,873        
Common shares issued upon exercise of warrants at $5.00 per share, net of issuance costs $ 1 17,234 0 0 17,234
Common shares issued upon exercise of warrants at $6.00 per share, net of issuance costs (in shares) 675,000        
Common shares issued upon exercise of warrants at $6.00 per share, net of issuance costs $ 0 3,847 0 0 3,847
Net unrealized gain on short-term investments $ 0 0 0 7 7
Sale of common stock and warrants at $6.00 per share in public offering, net of issuance costs (in shares) 2,066,667        
Sale of common stock and warrants at $6.00 per share in public offering, net of issuance costs $ 0 11,667 0 0 11,667
Balance (in shares) at Sep. 30, 2020 37,109,317        
Balance at Sep. 30, 2020 $ 4 69,181 (21,754) 7 47,437
Balance (in shares) at Jun. 30, 2020 34,361,591        
Balance at Jun. 30, 2020 $ 3 54,973 (17,892) 0 37,084
Common shares issued upon exercise of stock options (in shares) 34,250        
Common shares issued upon exercise of stock options $ 0 52 0 0 52
Common shares issued upon vesting of restricted stock units (in shares) 14,999        
Common shares issued upon vesting of restricted stock units $ 0 0 0 0 0
Share-based compensation expense 0 546 0 0 546
Net loss for the period $ 0 0 (3,862) 0 (3,862)
Common shares issued upon exercise of warrants at $6.50 per share (in shares) 177,986        
Common shares issued upon exercise of warrants at $6.50 per share $ 0 1,102 0 0 1,102
Common shares issued upon exercise of warrants at $3.00 per share, net of issuance costs (in shares) 102,621        
Common shares issued upon exercise of warrants at $3.00 per share, net of issuance costs $ 0 295 0 0 295
Common shares issued upon exercise of warrants at $5.00 per share, net of issuance costs (in shares) 1,742,870        
Common shares issued upon exercise of warrants at $5.00 per share, net of issuance costs $ 1 8,366 0 0 8,366
Common shares issued upon exercise of warrants at $6.00 per share, net of issuance costs (in shares) 675,000        
Common shares issued upon exercise of warrants at $6.00 per share, net of issuance costs $ 0 3,847 0 0 3,847
Net unrealized gain on short-term investments $ 0 0 0 7 7
Balance (in shares) at Sep. 30, 2020 37,109,317        
Balance at Sep. 30, 2020 $ 4 69,181 (21,754) 7 47,437
Balance (in shares) at Dec. 31, 2020 37,554,162        
Balance at Dec. 31, 2020 $ 4 71,705 (25,310) 15 $ 46,414
Common shares issued upon exercise of stock options (in shares) 915,404       915,404
Common shares issued upon exercise of stock options $ 0 1,678 0 0 $ 1,678
Common shares issued upon vesting of restricted stock units (in shares) 421,407        
Common shares issued upon vesting of restricted stock units $ 0 0 0 0 0
Share-based compensation expense 0 4,310 0 0 4,310
Net unrealized loss on short-term investments 0 0 0 (4) (4)
Net loss for the period $ 0 0 (19,220) 0 (19,220)
Common shares issued upon exercise of warrants at $6.50 per share (in shares) 1,661,320        
Common shares issued upon exercise of warrants at $6.50 per share $ 0 10,799 0 0 10,799
Common shares issued upon exercise of warrants at $8.125 per share (in shares) 153,692        
Common shares issued upon exercise of warrants at $8.125 per share $ 0 1,249 0 0 1,249
Common shares issued for services (in shares) 42,876        
Common shares issued for services $ 0 239 0 0 239
Balance (in shares) at Sep. 30, 2021 40,748,861        
Balance at Sep. 30, 2021 $ 4 89,979 (44,530) 11 45,464
Balance (in shares) at Jun. 30, 2021 39,911,390        
Balance at Jun. 30, 2021 $ 4 87,277 (38,539) 13 48,755
Common shares issued upon exercise of stock options (in shares) 758,338        
Common shares issued upon exercise of stock options $ 0 1,399 0 0 1,399
Common shares issued upon vesting of restricted stock units (in shares) 79,133        
Common shares issued upon vesting of restricted stock units $ 0 0 0 0 0
Share-based compensation expense 0 1,303 0 0 1,303
Net unrealized loss on short-term investments 0 0 0 (2) (2)
Net loss for the period $ 0 0 (5,991) 0 (5,991)
Balance (in shares) at Sep. 30, 2021 40,748,861        
Balance at Sep. 30, 2021 $ 4 $ 89,979 $ (44,530) $ 11 $ 45,464